Unicellab co.
Latest round
- Series A
Last raised
- Dec 2019
Total raised
- $2.2M
Investors
- 3
About Unicellab co.
, operates as a developer and manufacturer of raw materials used in crystallization medicine., ltd. As of 2020, Ahn Ji-hoon acts as the CEO of the company. The company offers APIs (active pharmaceutical ingredients) through research and development of crystal forms of raw materials for various pharmaceutical usages. The company uses co-crystal technology for the development of polycrystalline polymorphs, salts, and amorphous substances.
Who invested in Unicellab co.
3 investors across 1 round
See all investors in Unicellab co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 31, 2019
Amount
$2.2M
Investors
Questions about Unicellab co.
Who invested in Unicellab co.?
Unicellab co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Unicellab co. raised?
Unicellab co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Unicellab co. last raise money?
Unicellab co.'s most recent round on record is a Series A, in Dec 2019.
What does Unicellab co. do?
, operates as a developer and manufacturer of raw materials used in crystallization medicine.
Where is Unicellab co. headquartered?
Unicellab co. is headquartered in Uiwang, South Korea.
Which VCs invest in companies like Unicellab co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Unicellab co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Unicellab co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.